Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Furuhashi

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2023
Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical databaseYu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Blood Purification|August 28, 2025
Evaluation of the therapeutic effects of beta2-microglobulin adsorption on dialysis-related amyloidosis using a clinical claims databaseChikao Onogi, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Frontiers in Medicine|June 17, 2022
Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea SyndromeYu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Clinical Kidney Journal|February 26, 2024
Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonateChikao Onogi, Yu Watanabe, Akihito Tanaka, et al.
Globalization and Health|November 8, 2022
Influence of COVID-19 on the 10-year carbon footprint of the Nagoya University Hospital and medical research centreHikaru Morooka, Takanori Yamamoto, Akihito Tanaka, et al.
Cureus|July 7, 2025
A Case of Cryoglobulinemic Nephritis That Responded to Rituximab MonotherapyKumiko Fujieda, Akihito Tanaka, Kayaho Maeda, et al.
Plos One|March 18, 2025
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocolShinobu Shimizu, Akihito Tanaka, Nao Matsuyama, et al.
CEN Case Reports|August 7, 2023
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits and atypical pathological findings treated with corticosteroid and rituximabMachi Mori, Akihito Tanaka, Kayaho Maeda, et al.
BMC Nephrology|May 4, 2023
Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims databaseTakuro Matsuzaki, Yu Watanabe, Akihito Tanaka, et al.
Redox Biology|July 13, 2026
Iron-catalyzed oxidative stress reveals an exposome-related ferroptosis-resistant karyomegalic niche in BRCA1-linked renal carcinogenesisYingyi Kong, Yukihiro Shiraki, Kazuhiro Furuhashi, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2023
Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical databaseYu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Blood Purification|August 28, 2025
Evaluation of the therapeutic effects of beta2-microglobulin adsorption on dialysis-related amyloidosis using a clinical claims databaseChikao Onogi, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Frontiers in Medicine|June 17, 2022
Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea SyndromeYu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Clinical Kidney Journal|February 26, 2024
Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonateChikao Onogi, Yu Watanabe, Akihito Tanaka, et al.
Globalization and Health|November 8, 2022
Influence of COVID-19 on the 10-year carbon footprint of the Nagoya University Hospital and medical research centreHikaru Morooka, Takanori Yamamoto, Akihito Tanaka, et al.
Cureus|July 7, 2025
A Case of Cryoglobulinemic Nephritis That Responded to Rituximab MonotherapyKumiko Fujieda, Akihito Tanaka, Kayaho Maeda, et al.
Plos One|March 18, 2025
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocolShinobu Shimizu, Akihito Tanaka, Nao Matsuyama, et al.
CEN Case Reports|August 7, 2023
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits and atypical pathological findings treated with corticosteroid and rituximabMachi Mori, Akihito Tanaka, Kayaho Maeda, et al.
BMC Nephrology|May 4, 2023
Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims databaseTakuro Matsuzaki, Yu Watanabe, Akihito Tanaka, et al.
Redox Biology|July 13, 2026
Iron-catalyzed oxidative stress reveals an exposome-related ferroptosis-resistant karyomegalic niche in BRCA1-linked renal carcinogenesisYingyi Kong, Yukihiro Shiraki, Kazuhiro Furuhashi, et al.
Pageof 7